Thursday, November 12, 2026 • 12:26 PM
  • Home
  • /
  • News
  • /
  • Rational Based Drug Design Summit Europe Returns to Amsterdam in January 2027
Pharma Consulting
News

Rational Based Drug Design Summit Europe Returns to Amsterdam in January 2027

The Rational Based Drug Design Summit Europe will take place on 13-14 January 2027 in Amsterdam, bringing together Europe's leading structural biologists, biophysicists, medicinal chemists, computational chemists, AI drug discovery specialists and pharmaceutical R&D leaders.

As the dedicated forum for advancing rational drug design, the summit will explore how structural biology, biophysics, medicinal chemistry and artificial intelligence are being integrated to improve target identification, molecular design, hit validation and candidate selection. Learn from scientific presentations, case studies, panel discussions designed to support the discovery of next-generation therapeutics.

Gain practical insights into reducing development risk, accelerating discovery timelines and addressing complex therapeutic challenges while connecting with peers from leading biopharmaceutical organisations across Europe.

To learn more about the event and view the full agenda, visit: https://ter.li/iha2lrdn




  • By Editorial Panel
  • 12 Nov 2026
Share Post:

Latest News

News Image
Pharma Consulting

Chief Nursing Officers to Conv...

By Editorial Panel, Pharma Busine...

News Image
Pharma Consulting

Chief Medical Officers to Conv...

By Editorial Panel, Pharma Busine...

News Image
Pharma Consulting

Saudi MedTech 2026 Unites Heal...

By Editorial Panel, Pharma Busine...

News Image
Pharma Consulting

Evolution Summit 2027 to Conve...

By Editorial Panel, Pharma Busine...

News Image
Pharma Consulting

PharmaMarketing Summit 2027 to...

By Editorial Panel, Pharma Busine...

Pharma Business Outlook

Pharma Business Outlook is more than just a publication—it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem.